Headquarters
1325 AVENUE OF THE AMERICAS FL 28, NEW YORK, NY 10019, US
NEW YORK, NY, US
BRAINSTORM CELL THERAPEUTICS INC
From the company
BrainStorm Cell Therapeutics Inc. (OTCQB: BCLI) is a clinical-stage biotechnology company focused on developing autologous cellular therapeutics for neurodegenerative diseases. Its proprietary NurOwn platform uses autologous mesenchymal stem cells to produce neurotrophic factor-secreting (MSC-NTF) cells, manufactured individually from each patient's bone marrow and delivered intrathecally. The company also has an allogeneic exosome platform.
Products & services offered
Capabilities 8
Classifications
- Ownership classifications (1)
- Self Certified Small Disadvantaged Business
Facilities
Send your requirements
Quantities, certifications, and timing.